Last updated 2026-08-23
Total raised
—
Last: Undisclosed Round 2023-04
Stage
Seed
Founded
2020
Headcount
3
HQ
Tel Aviv-Yafo, Israel
Sector
Biotechnology
About
101 Therapeutics is a biopharmaceutical company developing macrophage-targeted therapeutics for acute and chronic inflammatory diseases. Their goal is to cure infectious diseases by focusing on the underlying biological processes rather than just the pathogen causing the disease. The company is developing a novel COVID-19 treatment that binds to immune cells called macrophages to stop dangerous immune overreaction (cytokine storm) and eliminate the virus. Their approach is 'pathogen agnostic,' meaning it is designed to work against various mutations, variants, and future pathogens. They are also developing therapies for oncology, autoimmune, metabolic, rare diseases, and neuroinflammation.
Headcount over time
3 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Q&A
- What is 101 Therapeutics' primary focus?
- 101 Therapeutics is developing cures for multiple infectious diseases by targeting the host immune system with a targeted glucocorticoid.
- When was 101 Therapeutics founded?
- 101 Therapeutics was founded in November 2020.
- Where is 101 Therapeutics headquartered?
- 101 Therapeutics is headquartered in Tel Aviv-Yafo, Israel.
- What is the current employee count for 101 Therapeutics?
- 101 Therapeutics has 1-10 employees.
- What is 101 Therapeutics' current product stage?
- 101 Therapeutics' product is in the clinical trial stage.
- Which sector does 101 Therapeutics primarily operate in?
- 101 Therapeutics operates primarily in the Health Tech & Life Sciences sector.
- What is 101 Therapeutics' current funding stage?
- 101 Therapeutics is currently in the Seed funding stage.
- When was 101 Therapeutics' last funding round and who was a lead investor?
- 101 Therapeutics' last funding round was in April 2023, with Awz Ventures as a lead investor.
Team · 3
Dr. Michael Goldberg
Founder · CEO, Co-founder, Chief Scientific Officer
Alec Goldberg
Founder · Co-founder
James Goldberg
Founder · Co-founder
Sectors & technology
Primary sector
Biotechnology
Technologies
Business model
B2B
Tags
biotechnologypharmaceuticalsinfectious-diseasedrug-developmentdrug-discovery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | 101therapeutics.com/ |
|---|---|
| linkedin.com/company/70077086 |
Identifiers & details
| Legal name | 101 THERAPEUTICS LTD |
|---|---|
| Founded | 2020-11 |
| Employees (exact) | 3 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | 101therapeutics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516273422 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-11-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | דרך בגין 121 תל אביב - יפו |